These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 34222137

  • 1. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.
    Jiang D, Yuan X, Ni J, Shen L, Cai M, Xu L.
    Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
    [Abstract] [Full Text] [Related]

  • 2. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B, Liu X, Gao Y, Li L, Dong Z.
    Br J Biomed Sci; 2016 Oct 21; 73(4):152-157. PubMed ID: 27922430
    [Abstract] [Full Text] [Related]

  • 4. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
    Michael Traeger M, Rehkaemper J, Ullerich H, Steinestel K, Wardelmann E, Senninger N, Abdallah Dhayat S.
    J Cancer Res Clin Oncol; 2018 Dec 21; 144(12):2419-2431. PubMed ID: 30244390
    [Abstract] [Full Text] [Related]

  • 5. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD, Hu B, Cen G, Yang YH, Chen WW, Guo ZY, Wang XF, Zhao Q, Qiu ZJ.
    World J Gastroenterol; 2020 May 21; 26(19):2349-2373. PubMed ID: 32476798
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH, Shi M, Ni CR, Zhu MH.
    Oncol Rep; 2014 Mar 21; 31(3):1157-64. PubMed ID: 24398877
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.
    Huang WT, Lin TS, Wu JY, Hong JM, Chen YL, Qiu FN.
    Eur Rev Med Pharmacol Sci; 2022 Jul 21; 26(13):4638-4653. PubMed ID: 35856354
    [Abstract] [Full Text] [Related]

  • 8. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C, Qi X.
    J Clin Lab Anal; 2020 Oct 21; 34(10):e23442. PubMed ID: 32592206
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
    Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, Shi M, Ni C, Zhu M.
    Oncol Rep; 2013 Jul 21; 30(1):276-84. PubMed ID: 23612862
    [Abstract] [Full Text] [Related]

  • 10. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 21; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
    Chung HW, Lim JB.
    J Transl Med; 2014 Apr 21; 12():102. PubMed ID: 24745825
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma.
    Gong Y, Song L, Ou L, Lu YY, Huang X, Zeng Q.
    Iran J Med Sci; 2023 Jul 21; 48(4):401-413. PubMed ID: 37456201
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma.
    Bai Z, Sun J, Wang X, Wang H, Pei H, Zhang Z.
    Oncol Rep; 2015 Aug 21; 34(2):595-602. PubMed ID: 26062664
    [Abstract] [Full Text] [Related]

  • 14. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M, Makino N, Ikeda Y, Matsuda A, Ito M, Kakizaki Y, Saito Y, Ishizawa T, Kobayashi T, Furukawa T, Ueno Y.
    PLoS One; 2016 Aug 21; 11(7):e0158669. PubMed ID: 27380024
    [Abstract] [Full Text] [Related]

  • 15. The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
    Long LM, Zhan JK, Wang HQ, Li S, Chen YY, Liu YS.
    Pathobiology; 2017 Aug 21; 84(1):38-48. PubMed ID: 27458977
    [Abstract] [Full Text] [Related]

  • 16. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.
    J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.
    Zhu ZM, Xu YF, Su QJ, Du JD, Tan XL, Tu YL, Tan JW, Jiao HB.
    Mol Cell Biochem; 2014 Mar 03; 388(1-2):39-49. PubMed ID: 24242138
    [Abstract] [Full Text] [Related]

  • 18. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma.
    Guo XB, Yin HS, Wang JY.
    Eur Rev Med Pharmacol Sci; 2018 Sep 03; 22(18):5892-5898. PubMed ID: 30280769
    [Abstract] [Full Text] [Related]

  • 19. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B, Izetti P, Gregório C, Macedo GS, Castro MA, Osvaldt AB, Matte U, Ashton-Prolla P.
    Pancreas; 2016 Jan 03; 45(1):84-92. PubMed ID: 26262588
    [Abstract] [Full Text] [Related]

  • 20. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z, Xu Y, Du J, Tan J, Jiao H.
    J Surg Oncol; 2014 Feb 03; 109(2):89-94. PubMed ID: 24166773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.